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Abstract 
Background 
Chronic illnesses are diseases of long duration and generally of slow progression. They cause 
significant quality of life impairment. The aim of this study was to analyse psychosocial 
predictors of quality of life and of subjective well-being in chronic Portuguese patients. 
Methods 
Chronic disease patients (n = 774) were recruited from central Portuguese Hospitals. 
Participants completed self-reported questionnaires assessing socio-demographic, clinical, 
psychosocial and outcome variables: quality of life (HRQL) and subjective well-being 
(SWB). MANCOVA analyses were used to test psychosocial factors as determinants of 
HRQL and SWB. 
Results 
After controlling for socio-demographic and clinical variables, results showed that 
dispositional optimism, positive affect, spirituality, social support and treatment adherence 
are significant predictors of HRQL and SWB. Similar predictors of quality of life, such as 
positive affect, treatment adherence and spirituality, were found for subgroups of disease 
classified by medical condition. 
Conclusions 
The work identifies psychosocial factors associated with quality of life. The predictors for the 
entire group of different chronic diseases are similar to the ones found in different chronic 
disease subgroups: positive affect, social support, treatment adherence and spirituality. 
Patients with more positive affect, additional social support, an adequate treatment adherence 
and a feel-good spirituality, felt better with the disease conditions and consequently had a 
better quality of life. This study contributes to understanding and improving the processes 
associated with quality of life, which is relevant for health care providers and chronic 
diseases support. 
Keywords 
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Background 
Living with a chronic disease is a demanding experience that can affect multiple aspects of an 
individual’s life, such as social, family and occupational functioning. The Centers for Disease 
Control and Prevention [1] define chronic diseases as non-communicable illnesses that are 
prolonged in duration, do not resolve spontaneously, and are rarely cured completely. 
Chronic diseases include heart disease, cancer, stroke, diabetes, arthritis, obesity, and others. 
They affect everyday life and require adjustment on multiple life domains: adjustment is 
defined as a response to a change in the environment that allows an organism to become more 
suitably adapted to that change [2,3]. Typically, chronic patients are responsible for the 
management of the psychosocial factors that contribute to their health-related quality of life 
(HRQL). 
Health-related quality of life (HRQL) is a construct reflecting the impact of health on overall 
well-being [4]. The World Health Organization (WHO) has further identified physical health, 
psychological state, level of independence, social relationships and relationship to salient 
features of the environment as core dimensions in determining life quality (WHOQOL Group 
1993). It goes beyond direct measures of population health, life expectancy and causes of 
death, and focuses on the impact health status has on quality of life. A related concept of 
HRQL is well-being, which assesses the positive aspects of a person’s life, such as positive 
emotions and life satisfaction [5]. 
Considering the influence of several factors, such as social support [6], optimism [7], 
personality factors [8] on HRQL, numerous studies have analysed associations between these 
factors with HRQL and with subjective well-being (SWB). Subjective well-being refers to 
people’s emotional and cognitive evaluations of their lives, and includes what people usually 
call happiness, peace, fulfilment, and life satisfaction [9]. 
Dispositional optimism is defined as the general expectation or belief in positive outcomes in 
the future [10]. It has been associated with a variety of positive outcomes related to well-
being [11], such as self-esteem, low depression, low negative emotions, and life satisfaction 
[12]. It also has been linked to indicators of quality of life, such as good health [12]. 
Therefore, given the impact that this variable exerts on HRQL, it appears important to know 
the ways through which optimism operates. 
Emotional circumstances have been linked with mental and physical functioning. The 
emotional experience is composed by two factors: positive affect and negative affect. Positive 
affect refers to the individual’s positive emotional states such as joy, interest, confidence and 
alertness. Negative affect refers to negative emotional states such as fear, sadness, anger, 
guilt, contempt and disgust [13]. Social support has been defined as “an avocation 
interpersonal process that is centred on the reciprocal exchange of information and in a 
specific context; it consists of emotional and instrumental support and can improve mental 
health” [14], pg. 5. Parker et al. [4] reported that social support was beneficial in helping 
individuals in stressful situations. Spirituality is defined in many ways and can differ 
according to different religions. It reflects a unique psychological dimension around which 
individuals organize their lives, goals, values and intentions. It offers hope and opportunities 
for personal growth, and enhances social support, conferring important benefits for 
chronically ill people. A spirituality orientation may ease living with health challenges [15-
17]. Treatment adherence is defined as the extent to which behaviour of a person is consistent 
with health care recommendations [18]. 
The importance of quality of life in chronic diseases has been increasingly recognized, given 
its implications for patients’ well-being, the use of health resources and a variety of elements 
that are required for a successful everyday life [2]. Several studies [10-13,15,19-21] tend to 
analyse quality of life in a specific chronic illness group and focus only on one or two 
exploratory (predictors) variables. The question of which variables affect the new life of 
chronic diseases patients is still a matter of debate. It will be necessary to further investigate 
the role of psychosocial variables in predicting quality of life in chronic patients to optimize 
understanding of their relationships and to design better intervention programs [22]. 
The main purpose of this study was to identify psychosocial predictors of HRQL and SWB in 
chronic Portuguese patients with the disease under control. The analyses were performed for 
the global group of several chronic diseases and in subgroups of diseases, which were divided 
according to medical condition. 
Methods 
Patients and design 
This cross sectional study included 774 chronic patients, having in common the fact that they 
have returned to everyday life after diagnosis and treatment prescription. These patients were 
approached directly by their physicians during the consultation in the outpatient departments 
of the central Portuguese Hospitals. Inclusion criteria were: 1) diagnosis of epilepsy, diabetes, 
multiple sclerosis, obesity, myasthenia gravis or cancer disease diagnosed at least 3 years 
prior the study; 2) age ≥17 years at the time of the interview; 3) educational level higher than 
6 years; 4) had return to usual daily life with disease under control; 5) no cognitive 
disturbances. Prior to data collection, ethical approval for this study was obtained from the 
institutions’ ethical committees. After a description of the study aims and of participants’ 
rights, all patients who met the inclusion criteria agreed to participate. 
Measures 
Patients completed self-reporting questionnaires to assess socio-demographic, clinical and 
psychosocial variables, quality of life - HRQL (three components: general well-being – 
GWB, physical health – PH and mental health – MH) and subjective well-being (SWB). 
Psychologists collected the data, after medical appointments. Severity of disease was 
assessed with an anchoring vignete scale [23] following the recommendations of Sen (2002) 
[24] and the Eurostat statistics report practices. The scale is similar to the pain severity scale 
[25]. 
Socio-demographic and clinical variables 
Socio-demographic and clinical information was obtained regarding sex, education, age, time 
since diagnosis and severity of disease perception (“generally, how do you classify your 
illness?” with an increasing scale from 1-nothing serious, to 11-very serious). 
Psychosocial variables 
Dispositional optimism 
Dispositional optimism was evaluated with the Life Orientation Test-Revised (LOT-R) [26]. 
The LOT-R was developed to assess individual differences in generalized optimism (e.g. “In 
uncertain times, I usually expect the best”) versus pessimism (e.g. “If something can go 
wrong for me, it will”). Validation of the Portuguese scale [27] showed similar characteristics 
to the original version. It consists of ten statements, in which three items reflect expectations 
for positive outcomes, three items reflect expectations for negative outcomes, and four are 
filter items. The optimism score was calculated by adding the three optimism questions and 
the pessimism score was calculated by adding the three pessimism questions The overall 
LOT-R score (range: 6–30) was calculated by reverse scoring the three pessimism scores, and 
summing responses to all six questions. Higher scores mean a higher degree of dispositional 
optimism. The Portuguese version shows a Cronbach alpha of 0.71. 
Positive and negative affect 
Affect was assessed using the Positive and Negative Affect Schedule (PANAS), constructed 
by Watson, Clark and Tellegen [28] which addresses both positive affect (PA) and negative 
affect (NA). The PANAS schedule was validated to the Portuguese population by Galinha 
and Pais Ribeiro [29]. The results revealed similar characteristics to the original version. 
Items were averaged to obtain scale scores (range: 1–5), and high scores of PA indicate more 
positive affect, or the extent to which the individual feels enthusiastic, active and alert. A 
higher score of NA indicates more negative affect, which reflects the individual’s aversive 
mood states and general distress. The Portuguese version found an internal consistency 0.86 
for the positive affect and 0.89 for the negative affect scales. 
Spirituality 
Pinto and Pais Ribeiro [30] developed a scale to evaluate the spirituality of the Portuguese 
population, which considers both religious/spiritual perceptions and the hope of the patient. 
The five items were rated on a Likert-type scale with the response options from "do not 
agree" to "strongly agree". The determination scores were obtained through elementary 
arithmetic procedures, without inversion or transformation of values (range: 1–4), with a 
resulting midpoint of 2.5 for each item. Therefore, when the scores assume a value above the 
midpoint, it can be affirmed that the dimension of spirituality is identified as relevant. For the 
global scale, the authors found an internal consistency of 0.74. 
Social support 
For the Portuguese population social support was assessed with the Social Support Survey 
(MOS) [31-33]. This is a multidimensional self-questionnaire that evaluates various 
dimensions of social support. The MOS consists of four separate social support subscales: 
emotional/informational, tangible, affectionate, and positive social interaction. An overall 
functional social support index is also used (range: 0–100). All subscales have shown strong 
reliability over time with a Cronbach alpha higher than 0.91. 
Treatment adherence 
To assess treatment adherence a Portuguese version of the questionnaire (Medida de Adesão 
aos Tratamentos), based on previous studies [34], was developed with seven items by 
Delgado and Lima [35]. The treatment adherence score is the mean of the items in which 
higher values mean better treatment adherence. The measure showed good internal 
consistency. 
Outcome variables 
Quality of life 
Health status perception was measured with the Medical Outcomes Study MOS 36-item 
Short-Form Health Survey (SF-36) [36], a 36-item questionnaire divided into eight 
dimensions that represent two major components: the physical and the mental components of 
health. In this study, we used the general dimension Well-Being that results from the IQOLA 
project [37], in which a second-order factor was found, with three components of SF-36 
(general well-being - GWB, physical health - PH and mental health - MH). Each scale is 
converted directly into a 0–100 scale on the assumption that each question carries equal 
weight, in which 100 represents the highest level. The Portuguese version of the MOS SF-36 
[38,39] shows good levels of internal consistency (Cronbach α of 0.70). 
Subjective well-being 
Subjective well-being was evaluated using the Portuguese version of the Personal Well-being 
scale, which includes seven areas (satisfaction with level of life, health, personal 
achievement, personal relationships, sense of safety, community connection and future 
security). The score is the average of the items, varying from 0 to 100, in which higher values 
represent better subjective well-being. The Portuguese version shows a Cronbach α of 0.81 
[40]. 
Statistical analysis 
Descriptive statistics were calculated to assess sample characteristics. Patients were classified 
by medical conditions into three groups: metabolic diseases (obesity and diabetes, 47.2%), 
neurologic (epilepsy, multiple sclerosis and myasthenia gravis, 25.7%) and cancer (27.1%). 
Pearson correlation was used to examine the associations between psychosocial and outcome 
(HRQL and SWB) variables. 
Multivariate Analysis of Covariance (MANCOVA) was used to identify independent 
predictors of quality of life and of subjective well-being, controlling for socio-demographic 
and clinical variables. This analysis, which takes into account the possible association 
between outcome variables, included as potential predictors dispositional optimism, positive 
and negative affect, social support, spirituality and treatment adherence. 
MANCOVA assumptions were evaluated. To achieve normality, physical and mental health 
components values were transformed into   1  	
 , where k was the maximum 
value that the variable takes [41] in this sample. Significant level was set at 0.05. All analyses 
were carried out using the Statistical Package for Social Sciences (SPSS, Version 20.0). 
Results 
Participant characteristics 
The sample included 774 chronic patients: 27.1% with cancer, 17.2% with diabetes, 12% 
with epilepsy, 2.2% with myasthenia gravis, 11.5% with multiple sclerosis and 30% with 
obesity. Socio-demographic and clinical characteristics of the group and subgroups of chronic 
disease patients are presented in Table 1. 
Table 1 Socio-demographic and clinical characteristics by group and subgroups of 
chronic diseases 
  Total group of 
chronic diseases 
Subgroups of chronic diseases 
  (n=774) Metabolic 
(n=365) 
Neurologic 
(n=199) 
Cancer 
(n=210) 
n (%)      
Sex      
 Male 228 (29.50) 91 (24.90) 68 (34.20) 69 (32.90) 
 Female 546 (70.5) 274 (75.10) 131 (65.80) 141 (67.10) 
Education Level      
 ≥9 
Years 
465 (60.10) 187 (51.20) 161 (80.90) 117 (55.70) 
 <9 Year 309 (39.90) 178 (48.80) 38 (19.10) 93 (44.30) 
Mean (SD)      
Age (years)  42.98 (11.55) 42.93 (0.64) 36.52 (0.61) 48.80 (0.71) 
Time since 
diagnosis (years) 
 12.82 (9.73) 14.19 (0.56) 14.44 (0.74) 9.01 (0.49) 
Severity of disease 
perception 
 6.56 (2.81) 7.29 (0.15) 5.50 (0.18) 6.34 (0.21) 
Associations between psychosocial variables and HRQL and SWB 
Table 2 displays the descriptive statistics and correlations between psychosocial variables and 
outcome variables (HRQL components and SWB). Negative affect showed a statistically 
significant inverse association with HRQL components and SWB. Dispositional optimism 
and positive affect had a significant positive association with HRQL components and SWB. 
Spirituality only had a significant positive correlation with SWB. The other psychosocial 
dimensions showed a statistically significant association with HRQL components and with 
SWB. Statistically significant correlations were also found between outcome variables. 
  
Table 2 Descriptive statistics; correlations between psychosocial variables and HRQL 
components and SWB 
 Mean SD DOp PA NA Sp SS TA GWB MH PH SWB 
Psychosocial Variables             
Disp. Optimism (DOp) 20.68 4.12 - 0.44* −0.43* 0.32* 0.32* 0.18* 0.40* 0.38* 0.21* 0.42* 
Positive Affect (PA) 2.94 0.78  - −0.18* 0.24* 0.32* 0.11* 0.41* 0.33* 0.24* 0.36* 
Negative Affect (NA) 1.96 0.75  - - −0.13* −0.25* −0.24* −0.49* −0.58* −0.37* −0.42* 
Spirituality (Sp) 2.71 0.75    - 0.26* 0.05 0.20* 0.15* 0.17 0.41* 
Social Support (SS) 68.55 21.37     - 0.14* 0.30* 0.32* 0.23* 0.34* 
Treatment Adherence (TA) 5.41 0.54      - 0.21* 0.22* 0.20* 0.19* 
Quality of Life Variables             
General well-being (GWB) 49.84 18.90       - 0.66* 0.71* 0.56* 
Mental health (MH) 66.65 25.14        - 0.65* 0.50* 
Physical health (PH) 63.99 26.47         - 0.43* 
Subjective well-being (SWB) 63.60 17.07          - 
* p<0.05. 
MANCOVA analysis 
Considering the associations between outcome variables, and controlling for socio-
demographic and clinical variables, further analysis was performed using MANCOVA. 
A statistically significant association was found between each of the psychosocial variables 
with the HRQL components and SWB (Table 3). 
Table 3 Psychosocial factors associated with HRQL and SWB results of multivariate 
tests of MANCOVA analysis* 
 Value Roy’s largest root F(4, 667) p Observed powera 
Dispositional Optimism 0.02 3.57 0.007 0.87 
Positive Affect 0.08 13.01 <0.001 1.00 
Negative Affect 0.32 53.45 <0.001 1.00 
Spirituality 0.13 21.24 <0.001 1.00 
Social Support 0.04 6.73 <0.001 0.99 
Treatment Adherence 0.02 2.89 0.022 0.78 
* Controlling for sex, age, education level, time since diagnosis and severity of disease perception. 
a
 The observed power gives the probability that the F test will detect the differences between groups equal to those implied 
by sample difference. 
The results, presented in Table 4, showed that dispositional optimism, positive and negative 
affect, spirituality, and treatment adherence, were associated with general well-being (all p < 
0.01); positive and negative affect, social support and treatment adherence were associated 
with physical health component (all p < 0.01); dispositional optimism, positive and negative 
affect, social support and treatment adherence were associated with mental health; and all 
psychosocial variables were associated with subjective well-being (all p < 0.01). 
  
Table 4 Factors associated with HRQL and with SWB and parameter estimates of 
MANCOVA analysis 
  Parameter estimates 
  F(1, 670) b (se) t p 
QoL - General Well-being Dispositional Optimism 12.20 0.56 (0.16) 3.49 0.001 
Positive Affect 44.94 5.54 (0.79) 6.70 <0.001 
Negative Affect 78.87 −7.32 (0.82) −8.88 <0.001 
Spirituality 8.44 2.28 (0.79) 2.91 0.004 
Social Support 1.28 0.03 (0.03) 1.13 0.259 
Treatment Adherence 6.20 2.56 (1.03) 2.49 0.013 
QoL - Physical Health Dispositional Optimism 1.79 −0.04 (0.03) −1.34 0.181 
Positive Affect 7.51 −0.40 (0.15) −2.74 0.006 
Negative Affect 15.89 0.60 (0.15) 3.99 <0.001 
Spirituality 2.10 0.21 (0.14) 1.45 0.148 
Social Support 9.32 −0.02 (0.01) −3.05 0.002 
Treatment Adherence 8.39 −0,55 (0.19) −2.89 0.004 
QoL - Mental Health Dispositional Optimism 5.29 −0.05 (0.02) −2.29 0.022 
Positive Affect 20.40 −0.45 (0.10) −4.52 <0.001 
Negative Affect 118.48 1.42 (0.10) 13.73 <0.001 
Spirituality 2.94 −0.17 (0.0) −1.72 0.087 
Social Support 7.43 −0.01 (0.01) −2.73 0.007 
Treatment Adherence 5.27 −0.22 (0.12) −2.25 0.022 
Subjective Well-being Dispositional Optimism 4.94 0.35 (0.16) 2.22 0.027 
Positive Affect 17.41 3.29 (0.79) 4.17 <0.001 
Negative Affect 47.09 −5.59 (0.81) −6.86 <0.001 
Spirituality 67.57 6.38 (0.78) 8.22 <0.001 
Social Support 17.88 0.12 (0.03) 4.23 <0.001 
Treatment Adherence 4.56 2.17 (1.05) 2.14 0.033 
More positive affect and better treatment adherence contributed to better general well-being, 
physical and mental health and subjective well-being. Dispositional optimism and spirituality 
enhanced the general well-being and subjective well-being of the patients. Results also 
indicated that dispositional optimism had a statistically significant positive impact on mental 
health. Good social support contributed to better physical and mental health, as well as 
improved subjective well-being. Negative affect behaved as a statistically significant negative 
predictor for all components of HRQL and SWB. 
Subgroups of chronic diseases 
Table 5 presents the descriptive statistics, mean (standard deviation), and correlations 
between psychosocial and the outcome variables (HRQL components and SWB), according 
to the subgroup of disease. 
  
Table 5 Descriptive statistics and correlations between psychosocial variables and 
HRQL components and SWB, for subgroups of disease 
 Mean (SD) GWB MH PH SWB 
 M N C M N C M N C M N C M N C 
Psychosocial Variables                
Disp. Optimism (DOp) 20.1 (4.14) 20.77 (4.47) 21.61 (3.54) 0.40* 0.40* 0.35* 0.37* 0.41* 0.35* 0.18* 0.22* 0.23* 0.40* 0.40* 0.44* 
Positive Affect (PA) 2.86 (0.79) 3.01 (0.79) 3.02 (0.76) 0.44* 0.27* 0.43* 0.33* 0.33* 0.32* 0.25* 0.097 0.33* 0.35* 0.27* 0.41* 
Negative Affect (NA) 2.08 (0.82) 1.83 (0.68) 1.86 (0.66) −0.47* −0.51* −0.44* −0.59* −0.61* −0.50* −0.34* −0.40* −0.34* −0.42* −0.35* −0.41* 
Spirituality (Sp) 2.65 (0.77) 2.63 (0.74) 2.88 (0.71) 0.21* 0.13 0.16* 0.16* 0.06 0.20& 0.01 −0.05 0.09 0.42* 0.30* 0.48* 
Social Support (SS) 66.74 
(21.44) 
71.34 
(20.37) 
69.10 
(21.97) 
0.37* 0.12 0.30* 0.35* 0.21* 0.31* 0.28* −0.004 0.29* 0.48* 0.25* 0.27* 
Treatment Adherence (TA) 5.22 (0.59) 5.51 (0.44) 5.64 (0.41) 0.15* 0.06 0.22* 0.18* 0.22* 0.16* 0.18* 0.16* 0.17* 0.14* 0.12 0.60& 
Quality of Life Variables                
General well-being (GWB) 45.59 
(19.21) 
52.01 
(16.78) 
55.17 
(18.60) 
- - - 0.68* 0.58* 0.66* 0.71* 0.64* 0.74* 0.56* 0.50* 0.54* 
Mental health (MH) 62.63 
(25.90) 
70.46 
(22.82) 
69.98 
(24.97) 
0.71* 0.58* 0.66* - - - 0.64* 0.60* 0.67* 0.51* 0.44* 0.48* 
Physical health (PH) 59.83 
(28.14) 
68.06 
(24.26) 
67.37 
(24.41) 
0.68* 0.64* 0.74* 0.64* 0.60* 0.67* - - - 0.39* 0.41* 0.49* 
Subjective well-being 
(SWB) 
60.42 
(17.84) 
65.27 
(15.50) 
67.52 
(16.16) 
0.56* 0.50* 0.54* 0.51* 0.44* 0.48* 0.39* 0.41* 0.49* - - - 
* p<0.001. 
& p<0.05. 
M – Metabolic Subgroup; N – Neurologic Subgroup; C – Cancer Subgroup. 
Generally, all psychosocial variables have a statistically significant association with outcome 
variables, in all subgroups of disease. For each subgroup of disease patients (metabolic, 
neurologic and cancer) negative affect showed a statistically significant inverse relation with 
HRQL components and SWB. For all subgroups of disease, only spirituality did not show a 
statistically significant association with physical health. 
For each subgroup of diseases (Table 6), most of the psychosocial variables were 
significantly associated with quality of life and subjective well-being, controlling for socio-
demographic and clinical variables. 
Table 6 Factors associated with HRQL and with SWB results of multivariate tests of 
MANCOVA analysis for subgroups of disease* 
 Value Roy’s largest root F(4, 667) F(4, 307) F(4, 667) p Observed power 
 M N C M N C M N C M N C 
Dispositional Optimism 0.02 0.04 0.19 1.74 1.76 0.77 0.142 0.14 0.55 0.53 0.53 0.24 
Positive Affect 0.09 0.09 0.12 7.23 4.00 4.36 <0.001 0.004 0.002 0.99 0.90 0.93 
Negative Affect 0.36 0.03 0.26 27.97 16.79 10.53 <0.001 <0.001 <0.001 1.00 1.00 1.00 
Spirituality 0.09 0.09 0.18 6.76 3.92 7.49 <0.001 0.005 <0.001 0.99 0.89 0.99 
Social Support 0.10 0.05 0.09 7.73 1.99 3.85 <0.001 0.098 0.005 0.99 0.59 0.89 
Treatment Adherence 0.03 0.03 0.01 2.53 1.29 0.41 0.041 0.274 0.804 0.71 0.40 0.14 
* Controlling for sex, age, education level, time since diagnostics and severity of disease perception. 
M – Metabolic Subgroup; N – Neurologic Subgroup; C – Cancer Subgroup. 
Chronic metabolic disease 
Results presented in Table 7 for the metabolic disease subgroup showed that an optimistic 
attitude contributes to better general well-being (p = 0.021). Positive and negative affect had 
a positive and negative, respectively, statistically significant association with all components 
of HRQL and SWB (all p < 0.01). More social support also contributed to better physical (p = 
0.023) and mental health (p = 0.025) and improved subjective well-being (p < 0.001). 
Adequate treatment adherence for patients with metabolic diseases contributed to better 
physical health (p = 0.002). 
Table 7 Factors associated with HRQL and with SWB and parameters estimates of 
MANCOVA analysis for subgroups of disease 
Parameter estimates 
  F(1, 
370) 
F(1, 
170) 
F(1, 
166) 
b (se) t p 
  M N C M N C M N C M N C 
QoL - General Well-
being 
Dispositional 
Optimism 
5.44 6.54 2.48 0.56 (0.24) 0.68 (0.27) 0.56 (0.35) 2.31 2.56 1.58 0.021 0.011 0.117 
Positive Affect 26.19 9.83 7.53 6.14 (1.20) 4.19 (1.34) 4.51 (1.64) 5.12 3.14 2.74 <0.001 0.02 0.007 
Negative Affect 28.67 40.02 13.52 −6.09 
(1.14) 
−9.71 
(1.54) 
−6.96 (1.89) −5.36 −6.33 −3.86 <0.001 <0.001 <0.001 
Spirituality 3.79 0.03 4.13 2.29 (1.18) 0.25 (1.43) 3.29 (1.62) 1.95 0.18 2.03 0.052 0.862 0.044 
Social Support 2.82 0.02 0.18 0.07 (0.04) −0.01 
(0.05) 
0.02 (0.05) 1.68 −0.15 0.42 0.094 0.879 0.673 
Treatment Adherence 2.28 1.56 1.36 2.12 (1.40) 2.76 (2.21) 3.08 (2.64) 1.51 1.25 1.17 0.132 0.213 0.244 
QoL - Physical Health Dispositional 
Optimism 
0.39 1.52 0.75 −0.02 
(0.04) 
−0.06 
(0.05) 
−0.07 (0.09) −0.63 1.23 −0.87 0.529 0.219 0.387 
Positive Affect 4.47 0.92 2.60 −0.38 
(0.18) 
−0.02 
(0.23) 
−0.64 (0.39) −2.11 −0.96 −1.61 0.035 0.339 0.015 
Negative Affect 12.28 20.17 <0.001 0.60 (0.17) 1.19 (0.26) <0.001 
(0.46) 
3.50 4.49 <0.001 0.001 <0.001 1.000 
Spirituality 0.22 1.23 1.09 0.08 (0.17) 0.27 (0.25) 0.40 (0.39) 0.46 1.11 1.04 0.643 0.269 0.298 
Social Support 5.25 1.83 11.86 −0.01 
(0.01) 
0.11 (0.01) −0.04 (0.01) −2.29 1.35 −3.44 0.023 0.178 0.001 
Treatment Adherence 9.91 4.57 0.81 −0.67 
(0.21) 
−0.82 
(0.38) 
−0.57 (0.64) −3.15 −2.14 −0.89 0.002 0.034 0.371 
QoL - Mental Health Dispositional 
Optimism 
1.21 2.40 1.85 −0.03 
(0.03) 
−0.06 
(0.04) 
−0.07 (0.05) −1.10 −1.55 −1.34 0.272 0.123 0.176 
Positive Affect 10.31 7.90 3.33 −0.46 
(0.14) 
−0.05 
(0.19) 
−0.04 (0.22) −3.21 −2.81 −1.82 0.001 0.006 0.007 
Negative Affect 99.35 52.97 37.85 1.36 (0.14) 1.55 (0.21) 1.55 (0.25) 9.97 7.28 6.15 <0.001 <0.001 <0.001 
Spirituality 0.36 0.01 3.96 −0.09 
(0.14) 
−0.02 
(0.19) 
−0.43 (0.22) −0.60 −0.11 −1.99 0.549 0.911 0.048 
Social Support 5.10 1.72 2.22 −0.01 
(0.01) 
0.01 (0.01) −0.01 (0.01) −2.26 −1.31 −1.49 0.025 0.192 0.138 
Treatment Adherence 2.09 3.18 0.50 −0.24 
(0.17) 
−0.55 
(0.31) 
−0.25 (0.35) −1.45 −1.78 −0.71 0.149 0.076 0.481 
Subjective Well-being Dispositional 
Optimism 
2.38 1.29 0.95 0.37 (0.24) 0.34 (0.29) 0.32 (0.32) 1.54 1.13 0.98 0.121 0.258 0.330 
Positive Affect 4.01 3.17 15.75 2.39 (1.19) 2.67 (1.50) 5.89 (1.48) 2.00 1.78 3.97 0.046 0.077 <0.001 
Negative Affect 24.09 12.03 8.87 −5.54 
(1.13) 
−5.97 
(1.72) 
−5.08 (1.71) −4.91 −3.47 −2.98 <0.001 0.001 0.003 
Spirituality 21.08 9.40 25.98 5.37 (1.17) 4.92 (1.60) 7.46 (1.46) 4.59 3.07 5.09 <0.001 0.003 <0.001 
Social Support 28.84 0.25 0.16 0.23 (0.04) 0.03 (0.05) 0.02 (0.05) 5.37 0.49 0.40 <0.001 0.621 0.688 
Treatment Adherence 0.56 1.18 0.52 1.04 (1.39) 2.69 (2.49) 1.71 (2.38) 0.75 1.09 0.72 0.456 0.279 0.473 
M – Metabolic Subgroup; N – Neurologic Subgroup; C – Cancer Subgroup. 
Chronic neurologic disease 
In patients with chronic neurologic diseases, negative affect had a statistically significant 
negative impact in all components of HRQL and SWB (all p < 0.01). Positive affect was 
statistically associated with better general well-being (p = 0.02) and improved mental health 
(p = 0.006). More optimistic attitude developed better general well-being (p = 0.011), 
adequate treatment adherence contributed to enhanced physical health (p = 0.034), and feel-
good spirituality enhanced subjective well-being (p = 0.003) (Table 7). 
Cancer chronic disease 
For the cancer chronic disease subgroup, positive affect and spirituality showed a statistically 
significant association with general well-being and mental health components, and with 
subjective well-being (all p < 0.01). More optimistic patients and those with feel-good 
spirituality had better quality of life (in these domains). Negative affect had a negative, 
statistically significant, impact, and contributed to a negative predictor for general well-being 
(p < 0.001), mental health (p < 0.001) and subjective well-being (p = 0.003). Positive affect 
(p = 0.015) and more social support (p = 0.001) contributed to improved physical health 
(Table 7). 
Discussion 
The purpose of the present study was to explore the role of psychosocial factors in predicting 
quality of life in chronic Portuguese patients, controlling for socio-demographic and clinical 
variables. This study included a set of chronic disease patients and involved a variety of 
psychosocial variables. Several previous studies included only one specific disease and one 
psychosocial variable [11,20,21,42]. 
To summarize our findings, dispositional optimism, positive affect, spirituality, social support 
and treatment adherence are significant positive psychosocial predictors of quality of life. 
Positive and negative affect have a significantly positive and negative correlation with HRQL 
and with SWB, respectively. Similar findings are reported by Singh and Jha [13], especially 
regarding SWB. This study supports similar investigations, which also observed that positive 
affect was the strongest predictor of global well-being, and that life satisfaction was a 
function of the preponderance of positive affect in daily life. Dispositional optimism also had 
a positive correlation with HRQL and with SWB. Spirituality only had a positive significant 
moderate correlation with SWB. The results from our study are consistent with those reported 
by investigators studying cancer patients [43]. 
Furthermore, the findings of this study suggest that dispositional optimism associated with 
general and SWB and also exerts a statistically significant positive effect in mental health. 
Optimism may significantly influence mental and physical well-being [44] by the promotion 
of a healthy lifestyle, as well as adaptive behaviours and cognitive responses associated with 
greater flexibility, problem-solving capacity, and a more efficient treatment of negative 
information [44]. These results are consistent with previous studies [19,20] in which higher 
levels of optimism were prospectively associated with increased SWB. 
More positive affect and adequate treatment adherence are associated with a better HRQL 
and a better SWB. Negative affect behaves as a negative predictor of these components. In 
previous research an association between positive and negative affect and quality of life has 
been found: in a group of chronic patients (with arthritis, cardiovascular disease, chronic 
obstructive pulmonary disease or diabetes), high positive affect and low negative affect were 
associated with higher physical and mental health [45]. Similar results were found with blue-
collar women, with positive affect being related to women's self-reported health and exercise. 
Alternatively, negative affect was strongly correlated with complaints in a wide range of 
health problems [21]. 
Results also showed that spirituality was associated to a better HRQL and SWB. Visser, 
Garssen and Vingerhoets [43] stated that spirituality was defined as an experience of a 
connection with the essence of life. These authors found a positive association between 
spirituality and well-being in a majority of cancer cross-sectional studies. In a rheumatoid 
arthritis study, authors verified that spirituality may facilitate and improve emotional status 
and resilience, by experiencing more positive feelings and attending to the positive elements 
of life [46]. 
Another finding was that good social support was associated with better physical and mental 
health and to better SWB. Yang and al. [47] also demonstrated that social support has a 
positive relationship with physical and psychological well-being. Controlling for 
demographic variables, Tang et al. [42] found that in a group of diabetes patients social 
support was a positive predictor of quality of life. The positive relationship between social 
support and HRQL, in cancer patients underscores the importance of social support as a 
beneficial resource in sustaining an acceptable HRQL [48]. 
This study analysed simultaneously and found associations between psychosocial variables 
and HRQL, in different subgroups of chronic diseases treated together (metabolic, neurologic 
and cancer). We found that the three subgroups had similar psychosocial predictors of 
HRQL. In all subgroups, more positive affect was associated with better general well-being 
and mental health. People that feel-good spiritually experience had better SWB. In the 
metabolic and neurologic chronic disease subgroup, it was found that adequate treatment 
adherence were associated with better physical health. Social support was a better predictor 
of physical health in the metabolic and cancer disease subgroup. In general, in all subgroups, 
negative affect behaves as a negative predictor of HRQL. 
The predictors of HRQL for all groups of chronic diseases are similar to those found in 
different chronic disease subgroups: positive affect, social support, treatment adherence and 
spirituality. Patients who had more positive affect, additional social support, and adequate 
treatment adherence or feel-good spirituality, handled disease conditions better and 
consequently had a better HRQL. 
Conclusions 
This work was an attempt to identify psychosocial factors associated with HRQL in persons 
with chronic diseases. This study contributed to understanding and improving the processes 
associated with HRQL, which is relevant for health care providers, and chronic diseases 
support. A better understanding of the psychosocial factors that simplify the daily lives of 
patients ought to lead to better control of the disease, which should lead to better outcomes 
for patients, and reduced treatment costs. 
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